Advertisement

Folia Microbiologica

, Volume 50, Issue 3, pp 179–186 | Cite as

Role of the leukemia-inhibitory factor gene mutations in infertile women: The embryo-endometrial cytokine cross talk during implantation — a delicate homeostatic equilibrium

  • M. Králíčková
  • P. Šíma
  • Z. Rokyta
Review

Abstract

Locally secreted cytokines of both the embryonic and the endometrial origin control the implantation process. The defects in their signaling that lead to unfavorable environment within the uterus may cause embryo implantation failure. The leukemia inhibitory factor (LIF), interleukin-11 (IL-11) as well as IL-12/IL-15/IL-18 system are regarded to be important signaling vectors. LIF plays an essential role in the preimplantation embryo development and the blastocyst implantation and its gene mutations in women contribute to the implantation failure and subsequent infertility. IL-11 signaling has been shown to be required for the uterine decidualization response as well as for the hatching and attachment of blastocysts. The IL-12/IL-15/IL-18 system interacts with endometrial leukocytes, particularly with NK cells, and influences directly the local angiogenesis and tissue remodeling. Differences in the levels of endometrial leukocytic subpopulations and in the patterns of intra-uterine cytokine concentrations that are observed between fertile and infertile women contribute to infertility probably by affecting the embryonic maternal dialogue during the implantation and early placentation period. Focusing on this cross talk promises to open new era in assisted reproduction techniques that will be based on diagnostics of missing signaling molecules and impairments of uterine receptivity as well as on therapeutic applications of individualized embryo culture and transfer media.

Keywords

Assisted Reproductive Technology Leukemia Inhibitory Factor Infertile Woman Embryo Implantation Human Endometrium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

ART

assisted reproduction techniques

IL

interleukin

IVF

in vitro fertilization

LIF

leukemia inhibitory factor

LIF-R

LIF receptor

VEGF

vascular endothelial growth factor

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arck P.: Stress and embryo implantation.J.Gynecol.Obstet.Biol.Reprod.(Paris)33, S40-S42 (2004).Google Scholar
  2. Arici A., Engin O., Attar E., Olive D.L.: Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium.J.Clin.Endocrinol.Metab.80, 1908–1915 (1995).PubMedCrossRefGoogle Scholar
  3. Basak S., Dubanchet S., Zourbas S., Chaouat G., Das C.: Expression of pro-inflammatory cytokines in mouse blastocysts during implantation: modulation by steroid hormones.Am.J.Reprod.Immunol.47, 2–11 (2002).PubMedCrossRefGoogle Scholar
  4. Bedecarrats G.Y., Linher K.D., Janovick J.A., Beranova M., Kada F., Seminara S.B., Michael Conn P., Kaiser U.B.: Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function.Mol.Cell.Endocrinol.31, 51–64 (2003).CrossRefGoogle Scholar
  5. Beer A.E., Kwak J.Y., Ruiz J.E.: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failedin vitro fertilization cycles.Am.J.Reprod.Immunol.35, 376–382 (1996).PubMedGoogle Scholar
  6. Beranova M., Oliveira L.M.B., Bedecarrats G.Y., Schipani E., Vallejo M., Ammini A.C., Quintos J.B., Hall J.E., Martin K.A., Hayes F.J., Pitteloud N., Kaiser U., Crowley W.F. Jr,Seminara S.B.: Incidence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism.J.Clin.Endocrinol.Metab.86, 1580–1588 (2001).PubMedCrossRefGoogle Scholar
  7. Bergart A.M.: The experience of women in unsuccessful infertility treatment: what do patients need when medical intervention fails?Soc.Work Health Care30, 45–69 (2000).PubMedCrossRefGoogle Scholar
  8. Borini A., Bulletti C., Cattoli M., Serrao L., Polli V., Alfieri S., Flamigni C.: Use of recombinant leukemia inhibitory factor in embryo implantation.Am.N.Y.Acad.Sci.828, 157–161 (1997).CrossRefGoogle Scholar
  9. Bornstein S.R., Rutkowski H., Vrezas I.: Cytokines and steroidogenesis.Mol.Cell.Endocrinol.215, 135–141 (2004).PubMedCrossRefGoogle Scholar
  10. Brandt K.H., Zech H.: Results of a prognosis study ofin vitro fertilization after brief psychotherapy.Geburtshilfe Frauenheilkd.52, 297–300 (1992).PubMedCrossRefGoogle Scholar
  11. Caluwaerts S., Pijnenborg R., Luyten C., Keith J.C. Jr.,Van Assche F.A.: Differential effects of IL-11 on rat blastocysts and decidua during the peri-implantation period.Am.J.Reprod.Immunol.47, 231–241 (2002).PubMedCrossRefGoogle Scholar
  12. Chaouat G., Zourbas S., Ostojic S., Lappree-Delage G., Dubanchet S., Ledee N., Martal J.: A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical TH1/TH2 dichotomy.J.Reprod.Immunol.53, 241–256 (2002).PubMedCrossRefGoogle Scholar
  13. Chaouat G., Ledee-Bataille N., Dubanchet S., Zourbas S., Sandra O., Martal J.: Reproductive immunology 2003: reassessing the TH1/TH2 paradigm?Immunol.Lett.92, 207–214 (2004).PubMedCrossRefGoogle Scholar
  14. Charnock-Jones D.D., Sharkey A.M., Fenswick P., Smith S.K.: Leukemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implatation and the blastocyst contains mRNA for the receptor at this time.J.Reprod.Fertil.101, 421–426 (1994).PubMedGoogle Scholar
  15. Cheung L.P., Leung H.Y., Bongso A.: Effect of supplementation of leukemia inhibitory factor and epidermal growth factor on murine embryonic developmentin vitro, implantation, and outcome of offspring.Fertil.Steril.80 (Suppl. 2), 727–735 (2003).PubMedCrossRefGoogle Scholar
  16. Cullinan E.B., Abondanzo S.J., Anderson P.S., Pollard J.W., Lessey B.A., Steward C.L.: Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation.Proc.Nat.Acad.Sci.USA93, 3115–3120 (1996).PubMedCrossRefGoogle Scholar
  17. Delage G., Moreau J.F., Taupin J.L., Freitas S., Hambartsoumian E., Olivennes F., Fanchin R., Letur-Konirsh H., Frydman R., Chaouat G.:In-vitro endometrial secretion of human interleukin of DA cells/leukemia inhibitory factor by explant cultures from fertile and infertile women.Human Reprod.10, 2483–2488 (1995).Google Scholar
  18. Dominguez F., Pellicer A., Simon C.: The chemokine connection: hormonal and embryonic regulation at the human maternal-embryonic interface — a review.Placenta24 (Suppl. B), S48-S55 (2003).PubMedCrossRefGoogle Scholar
  19. Dunn C.L., Critchley H.O., Kelly R.W.: IL-15 regulation in human endometrial stromal cells.J.Clin.Endocrinol.Metab.87, 1898–1901 (2002).PubMedCrossRefGoogle Scholar
  20. Enders A.C., Mead R.A.: Progression of trophoblast into the endometrium during implantation in the western spotted skunk.Anat.Rec.244, 297–315 (1996).PubMedCrossRefGoogle Scholar
  21. Gao J.Q., Tsuda Y., Katayama K., Nakayama T., Hatanaka Y., Tani Y., Mizuguchi H., Hayakawa T., Yoshie O., Tsutsumi Y., Mayumi T., Nakagawa S.: Antitumor effect by interleukin-11 receptor α-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenvirus vector.Cancer Res.63, 4420–4425 (2003).PubMedGoogle Scholar
  22. Giess R., Tanasescu I., Steck T., Sendtner M.: Leukemia inhibitory factor gene mutations in infertile women.Mol.Hum.Reprod.5, 581–586 (1999).PubMedCrossRefGoogle Scholar
  23. Gubbay O., Critchley H.O., Bowen J.M., King A., Jabbour H.N.: Prolactin induces ERK phosphorylation in epithelial and CD56(+) natural killer cells of the human endometrium.J.Clin.Endocrinol.Metab.87, 2329–2335 (2002).PubMedCrossRefGoogle Scholar
  24. Haines B.P., Voyle R.B., Pelton T.A., Forrest R., Rathien P.D.: Complex conserved organization of the mammalian leukemia inhibitory factor gene: regulated expression of intracellular and extracellular cytokines.J.Immunol.162, 4637–4646 (1999).PubMedGoogle Scholar
  25. Hambartsoumian E.: Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation.Am.J.Reprod.Immunol.39, 137–143 (1998).PubMedGoogle Scholar
  26. Herrler A., von Rango U., Beier H.M.: Embryo-maternal signaling: how the embryo starts talking to its mother to accomplish implantation.Reprod.Biomed.Online6, 244–256 (2003).PubMedCrossRefGoogle Scholar
  27. Jokhi P.P., King A., Sharkey A.M., Smith S.K., Loke Y.W.: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction.J.Immunol.153, 4427–4435 (1994).PubMedGoogle Scholar
  28. Keltz M.D., Attar E., Buradaqunta S., Olive D.L., Kliman H.J., Arici A.: Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube.Am.J.Obstet.Gynecol.175, 1611–1619 (1996).PubMedCrossRefGoogle Scholar
  29. Klentzeris L.D., Bulmer J.N., Warren M.A., Morrison L., Li T.C., Cooke I.D.: Lymphoid tissue in the endometrium of women with unexplained infertility: morphometric and immunohistochemical aspects.Human Reprod.9, 646–652 (1994).Google Scholar
  30. Kojima K., Kanzaki K., Iwai M., Hatayama H., Fujimoto M., Inoue T., Horie K., Nakayama N., Fujita J., Mori T.: Expression of leukemia inhibitory factor in human endometrium and placenta.Biol.Reprod.50, 882–887 (1994).PubMedCrossRefGoogle Scholar
  31. Králíčková M., Šíma P., Rokyta Z., Ulčová-Gallová Z., Suchá R., Uher P., Vaněček T., Šíma R., Hes O.: Leukemia inhibitory factor gene mutations in the population of infertile women are not restricted to nulligravid patients.Europ.J.Obstet.Gynecol., in press (2005).Google Scholar
  32. Krussel J.S., Bielfeld P., Polan M.L., Simon C.: Regulation of embryonic implantation.Eur.J.Obstet.Gynecol.Reprod.Biol.110 (Suppl. 1), S2-S9 (2003).PubMedCrossRefGoogle Scholar
  33. Kubrycht J., Malíková P., Huan N.H., Fišerová A., Bezouška K., Kružík P., Stajner K., Moravec V., Pospíšil M.: Peripheral membrane molecules of leukocytes and NK cytotoxicity.Folia Microbiol.38, 421–431 (1993).CrossRefGoogle Scholar
  34. Laird S.M., Tuckerman E.M., Dalton C.F., Dunphy B.C., Li T.C., Zhang T.: The production of leukemia inhibitory factor by human endometrium: presence in uterine flushings and production by cells in culture.Human Reprod.12, 569–574 (1997).CrossRefGoogle Scholar
  35. Le Bouteiller P.: The role of HLA-G expression in the embryo during implantation.J.Gynecol.Obstet.Biol.Reprod.(Paris)33, S9-S12 (2004).Google Scholar
  36. Ledee-Bataille N., Koeppel B., Frydman R., Chaouat G.: The impact of stress in the maternofetal relationship: an immunological approach.Gynecol.Obstet.Fertil.31, 778–781 (2003).PubMedCrossRefGoogle Scholar
  37. Ledee-Bataille N., Dubanchet S., Coulomb-L’Hermine A., Durand-Gasselin I., Frydman R., Chaouat G.: A new role for natural killer cells, interleukin (IL)-12, and IL-18 in repeated implantation failure afterin vitro fertilization.Fertil.Steril.81, 59–65 (2004a).PubMedCrossRefGoogle Scholar
  38. Ledee-Bataille N., Olivennes F., Kadoch J., Dubanchet S., Frydman N., Chaouat G., Frydman R.: Detectable levels of interleukin-18 in uterine luminal secretions at oocyte retrieval predict failure of the embryo transfer.Human Reprod.19, 1968–1973 (2004b).CrossRefGoogle Scholar
  39. Lei T., Yang Z.Q., Xia T., Gan L., Chen X.D., Yuan J.H., Zhu Y.: Stage-specific expression of leukemia inhibitory factor and its receptor in rabbit pre-implantation embryo and uterine epithelium during early pregnancy.Reprod.Domest.Anim.39, 13–18 (2004).PubMedCrossRefGoogle Scholar
  40. Metcalf D.: The unsolved enigmas of leukemia inhibitory factor.Stem Cells21, 5–14 (2003).PubMedCrossRefGoogle Scholar
  41. Mikolajczyk M., Skrzypczak J., Szymanowski K., Wirstlein P.: The assessment of LIF in uterine flushing — a possible new diagnostic tool in states of impaired fertility.Reprod.Biol.3, 259–270 (2003).PubMedGoogle Scholar
  42. Moffett-King A.: Natural killer cells and pregnancy.Nature Rev.Immunol.2, 656–663 (2002).CrossRefGoogle Scholar
  43. Nardo L.G., Nikas G., Makrigiannakis A.: Molecules in blastocyst implantation. Role of matrix metalloproteinases, cytokines and growth factors.J.Reprod.Med.48, 137–147 (2003).PubMedGoogle Scholar
  44. Piccinni M.P., Scaletti M.P., Vultaggio A., Maggi E., Romagnani S.: Defective production of LIF, M-CSF and TH2-type cytokines by T cells at fetomaternal interface is associated with pregnancy loss.J.Reprod.Immunol.52, 35–43 (2001).PubMedCrossRefGoogle Scholar
  45. Robb L., Dimitriadis E., Li R., Salamonsen L.A.: Leukemia inhibitory factor and interleukin-11: cytokines with key roles in implantation.J.Reprod.Immunol.57, 129–141 (2002).PubMedCrossRefGoogle Scholar
  46. Romero R., Espinoza J., Mazor M.: Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth afterin vitro fertilization?Fertil.Steril.82, 799–804 (2004).PubMedCrossRefGoogle Scholar
  47. Saito S., Nishikawa K., Morii T., Enomoto M., Narita N., Motoyoshi K., Ichijo M.: Cytokine production by CD16–CD56bright natural killer cells in the human early pregnancy decidua.Internat.Immunol.5, 559–563 (1993).CrossRefGoogle Scholar
  48. Schofield G., Kimber S.J.: Leukocyte subpopulations in the uteri of leukemia inhibitory factor knockout mice during early pregnancy.Biol.Reprod.72, 872–878 (2005).PubMedCrossRefGoogle Scholar
  49. Sharkey A.M., King A., Clark D.E., Burrows T.D., Jokhi P.P., Charnock-Jones D.S., Loke Y.W., Smith S.K.: Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy.Biol.Reprod.60, 355–364 (1999).PubMedCrossRefGoogle Scholar
  50. Sherwin J.R., Smith S.K., Wilson A., Sharkey A.M.: Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility.J.Clin.Endocrinol.Metab.87, 3953–3960 (2002).PubMedCrossRefGoogle Scholar
  51. Sherwin J., Freeman T., Stephens R., Kimber S., Smith A., Chambers I., Smith S., Sharkey A.: Identification of genes regulated by leukaemia inhibitory factor in the mouse uterus at the time of implantation.Mol.Endocrinol.18, 2185–2195 (2004).PubMedCrossRefGoogle Scholar
  52. Sirisathien S., Hernandez-Fonseca H.J., Bosch P., Hollet B.R., Lott J.D., Brackett B.G.: Effect of leukemia inhibitory factor on bovine embryos producedin vitro under chemically defined conditions.Theriogenology59, 1751–1763 (2003).PubMedCrossRefGoogle Scholar
  53. Šplíchal I., Trebichavský I.: Cytokines and other important inflammatory mediators in gestation and bacterial intraamniotic infections.Folia Microbiol.46, 345–351 (2001).CrossRefGoogle Scholar
  54. Stahl J., Gearing D.P., Willson T.A., Brown M.A., King J.A., Gough N.M.: Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and noncoding regions.J.Biol.Chem.265, 8833–8841 (1990).PubMedGoogle Scholar
  55. Steck T., Giess R., Suetterlin M.W., Bolland M., Wiest S., Poehls U.G., Dietl J.: Leukemia inhibitory factor (LIF) gene mutations in women with unexplained infertility and recurrent failure of implantation after IVF and embryo transfer.Eur.J.Obstet.Gynecol.Reprod.Biol.112, 69–73 (2004).PubMedCrossRefGoogle Scholar
  56. Stewart C.L., Kaspar P., Brunet L.J., Bhatt H., Gadi I., Kontgen F., Abbondanzo S.J.: Blastocyst implantation depends on maternal expression of leukemia inhibitory factor.Nature359, 76–79 (1992).PubMedCrossRefGoogle Scholar
  57. Stewart C.L.: Leukemia inhibitory factor and the regulation of pre-implantation development of the mammalian embryo.Mol.Reprod.Dev.39, 233–238 (1994).PubMedCrossRefGoogle Scholar
  58. Tabibzadeh S.: Molecular control of the implantation window.Human Reprod.Update4, 465–471 (1998).CrossRefGoogle Scholar
  59. Tsai H.D., Chang C.C., Hsieh Y.Y., Lo H.Y.: Leukemia inhibitory factor expression in different endometrial locations between fertile and infertile women throughout different menstrual phases.Assist.Reprod.Genet.17, 415–418 (2000).CrossRefGoogle Scholar
  60. Vogiagis D., Marsh M.M., Fry R.C., Salamonsen L.A.: Leukemia inhibitory factor in human endometrium throughout the menstrual cycle.J.Endocrinol.148, 95–102 (1996).PubMedCrossRefGoogle Scholar
  61. Vogiagis D., Salamonsen L.A.: Review: the role of leukemia inhibitory factor in the establishment of pregnancy.J.Endocrinol.160, 181–190 (1999).PubMedCrossRefGoogle Scholar
  62. Willson T.A., Metcalf D., Gough N.M.: Cross-species comparison of the sequence of the leukemia inhibitory factor gene and its protein.Eur.J.Biochem.204, 21–30 (1992).PubMedCrossRefGoogle Scholar

Copyright information

© Institute of Microbiology, Academy of Sciences of the Czech Republic 2005

Authors and Affiliations

  1. 1.Department of Obstetrics and Gynecology, University Hospital, Faculty of MedicineCharles UniversityPilsenCzechia
  2. 2.Department of Immunology and Gnotobiology, Institute of MicrobiologyAcademy of Sciences of the Czech RepublicPragueCzechia

Personalised recommendations